NR1I3
NR1I3 (nuclear receptor subfamily 1 group I member 3, also known as CAR, CAR1 and MB67) is a ligand-regulated transcription factor of the nuclear hormone receptor family. It is a key regulator of xenobiotic and endobiotic metabolism. Browse Assay Genie's current range of NR1I3 research reagents below, or read on for the biology behind the target.
NR1I3 is a DNA-binding transcription factor that regulates genes involved in drug metabolism and bilirubin clearance, including cytochrome P450 family members. It binds DNA as a monomer or as a heterodimer with the retinoid X receptor. UniProt annotation records that it binds and transactivates the retinoic acid response elements controlling expression of the retinoic acid receptor beta 2 and alcohol dehydrogenase 3 genes, and that it transactivates both the phenobarbital responsive element module of the human CYP2B6 gene and the CYP3A4 xenobiotic response element.
Unlike most nuclear receptors, NR1I3 is constitutively active in the absence of ligand, yet it remains regulated by both agonists and inverse agonists. Ligand binding results in translocation of the protein to the nucleus, where it activates or represses target gene transcription. Reported ligands include bilirubin, a variety of foreign compounds, steroid hormones and prescription drugs. UniProt lists the protein in the nucleus, cytoplasm and cytoskeleton.
The NR1I3 gene belongs to the nuclear hormone receptor family, NR1 subfamily, and is classed by HGNC in nuclear receptor subfamily 1 group I. Beyond drug metabolism, the CAR protein is reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation and circadian clock regulation. Multiple transcript variants encoding different isoforms have been described. The gene was formerly named nuclear receptor subfamily 1, group I, member 3, and mouse and rat orthologs are both designated Nr1i3.
NR1I3 regulates transcription of cytochrome P450 family members, making it central to how cells respond to foreign compounds and prescription drugs.
The receptor is activated by bilirubin and controls target genes involved in its clearance, linking it to endobiotic handling.
CAR is reported to regulate genes involved in glucose and lipid metabolism, so it is studied alongside other metabolic transcription factors.
Its constitutive activity, ligand-dependent nuclear translocation and heterodimerisation with retinoid X receptor make it a useful model of nuclear receptor regulation.
NR1I3 is a transcription factor that regulates genes involved in drug metabolism and bilirubin clearance, including cytochrome P450 family members. It binds DNA as a monomer or as a heterodimer with the retinoid X receptor, and activates or represses target genes after ligand-driven nuclear translocation.
NR1I3 is also known as CAR, CAR1 and MB67, and the CAR name is widely used for the protein. The previous HGNC name was nuclear receptor subfamily 1, group I, member 3. Multiple transcript variants encoding different isoforms have been reported for the gene.
Yes. Mouse and rat orthologs are both designated Nr1i3, so the gene can be studied in rodent models. Check the datasheet of any product for its validated reactivity.
Other nuclear receptors, including NR1 subfamily members and regulators of xenobiotic and metabolic transcription, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q14994; product specifications from Assay Genie datasheets.